Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Nuo Therapeutics Inc
AURXCurrent price
0.78 USD
0 USD (0.00%)
Last closed
0.78 USD
Company
www.nuot.com
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
OTCQB
Capitalization
33 201 358 USD
Yield for 12 month
+29.25 %
1Y
3Y
5Y
10Y
15Y
AURX
Nuo Therapeutics, Inc., a regenerative therapies company, develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States. The company offers the Aurix System, which separates autologous blood to produce a platelet-based therapy for the chronic wound care market. It serves hospital outpatient wound care clinics and other private practice physicians treating chronic wounds. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was incorporated in 1998 and is based in Houston, Texas. Address: 8285 El Rio, Houston, TX, United States, 77054
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
+608 525 USD
Last Year
+112 250 USD
Current Quarter
+364 773 USD
Last Quarter
+234 577 USD
Current Year
+482 433 USD
Last Year
+93 036 USD
Current Quarter
+299 438 USD
Last Quarter
+183 986 USD
Key Figures AURX
1 year
3 years
5 years
10 years
EBITDA
-2 677 912 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-119.97 %
PEG Ratio
–
Return On Equity TTM
-503.61 %
Wall Street Target Price
–
Revenue TTM
1 028 606 USD
Book Value
0.013 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
208.7 %
Dividend Yield
–
Gross Profit TTM
93 036 USD
Earnings per share
-0.07 USD
Diluted Eps TTM
-0.07 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-261.78 %
Dividend Analytics AURX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History AURX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation AURX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
32.0068
Price Sales TTM
32.278
Enterprise Value EBITDA
-67.3805
Price Book MRQ
55.4731
Financials AURX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators AURX
For 52 weeks
0.25 USD
0.98 USD
50 Day MA
0.63 USD
Shares Short Prior Month
–
200 Day MA
0.64 USD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart